当前位置：首页 > 文献互助 > 互助详情

RGLS8429-Mediated miR-17 Inhibition Leads to Acute PKD1/2 De-repression and Ameliorates Preclinical ADPKD复制

用户qF7pME5zq23w 1天前 40 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-07-31 12:27:21 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1681/asn.2024fvfc3k6z复制

文献链接: https://journals.lww.com/10.1681/ASN.2024fvfc3k6z复制

其他信息:

出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Ronak Lakhia; Jesus A. Alvarez; Harini Ramalingam; Patricia Cobo-Stark; Laurence Michael Biggers; Jianfeng Huang; Tania M. Valencia; Edmund Chun Yu Lee; Vishal Patel

上一篇：Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

下一篇：Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

互助时间线

2025-07-24 13:01:38 [完结求助]

楼主确认了用户k2tVHdT4KgfI应助的文件是正确的, 求助状态变成 已完结

2025-07-24 12:27:21 [上传文件]

用户k2tVHdT4KgfI上传了文件(pdf 132.03 KB), 求助状态变成 待确认

2025-07-24 10:36:25 [发起求助]

最新发布的求助

Evaluation and Management of the Physiologically Difficult Airway: Consensus Recommendations From Society for Airway Management 35分钟前
强直性脊柱炎诊疗规范 【中文期刊】 黄烽 朱剑 等 《中华内科杂志》 2022年61卷8期 893-900页 36分钟前
Population Pharmacokinetics and Pharmacodynamics Modeling for the Use of Recaticimab in Healthy Volunteers and Patients with Hypercholesterolemia 39分钟前
Sacroiliac joint fusion in patients with ankylosing spondylitis is associated with hip involvement 40分钟前
Recaticimab: First Approval 41分钟前
Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab 52分钟前
Safety of guselkumab and ustekinumab treatment in patients with moderate-to-severe plaque psoriasis combined with latent tuberculosis or inactive hepatitis B virus infection: A retrospective multicenter observational study 54分钟前
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones 1小时前
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis 1小时前
A bioprintable form of chitosan hydrogel for bone tissue engineering 2小时前
Veliparib: Analytical Tools and Process Design Strategies for the Control of Mutagenic Impurities and Other Drug Substance Critical Quality Attributes 2小时前
Glycogen synthase kinase 3β (GSK-3β) inhibitors - a patent update (2019–2024) 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com